1. Home
  2. MUJ vs PRTA Comparison

MUJ vs PRTA Comparison

Compare MUJ & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniHoldings New Jersey Quality Fund Inc.

MUJ

Blackrock MuniHoldings New Jersey Quality Fund Inc.

HOLD

Current Price

$12.13

Market Cap

631.8M

Sector

Finance

ML Signal

HOLD

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

HOLD

Current Price

$9.43

Market Cap

595.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUJ
PRTA
Founded
1998
2012
Country
United States
Ireland
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
631.8M
595.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MUJ
PRTA
Price
$12.13
$9.43
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$18.86
AVG Volume (30 Days)
108.0K
617.1K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
4.36%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$11,786,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$819.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.74
$4.32
52 Week High
$11.70
$17.66

Technical Indicators

Market Signals
Indicator
MUJ
PRTA
Relative Strength Index (RSI) 64.83 36.68
Support Level $11.96 $9.69
Resistance Level $12.09 $10.50
Average True Range (ATR) 0.10 0.57
MACD -0.00 -0.16
Stochastic Oscillator 82.86 6.50

Price Performance

Historical Comparison
MUJ
PRTA

About MUJ Blackrock MuniHoldings New Jersey Quality Fund Inc.

BlackRock MuniHoldings New Jersey Quality Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income tax and New Jersey personal income taxes. The fund mainly invests in long-term, investment-grade municipal obligations exempt from U.S federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax) and New Jersey personal income taxes, with remaining maturities of one year or more at the time of investment. The rest of its managed assets can be invested in securities that are rated below investment grade (or similar instruments), or invested directly in securities or synthetically through the use of derivatives.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: